A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Clinical trial NCT06685718 · TERMINATED

Trial details

NCT number: NCT06685718
Sponsor: BeOne Medicines
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Lung Cancer NSCLC NSCLC (Non-small Cell Lung Carcinoma)EGFR Activating Mutation EGFR Mutation-Related Tumors

Start date: 2024-12-05
Primary completion: 2026-04-21
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.